• Partnership seeks to improve Cryopreservation for Cell Therapies

News & Views

Partnership seeks to improve Cryopreservation for Cell Therapies

Cell therapy and regenerative medicine solutions provider Cyto-care.eu GmbH (Vienna) has signed an agreement with cell-based therapy and viral vectors CDMO SCTbio, to improve the quality of cryopreservation for cell therapy development in Europe, through addressing the critical need for efficient collection, cryopreservation, quality control and logistics capabilities of leukapheresis materials which support various aspects of the cell therapy workflow.

Cell collection through leukapheresis procedure is a key enabling step for manufacturing advanced cell therapies products (ATMPs), made from human cells or tissue that are life-saving therapies. The quantity and quality of collected immune cells, like T cells and natural killer cells used for cell therapies, directly impact the potency, safety and efficacy of the final therapeutic product. As such, efficient cryopreservation and logistics of these leukapheresis materials are critical to ensure the preservation of cell viability and functionality during transportation and storage.

Ludek Sojka, CEO of Czech Republic-based SCTbio, stated, “We are thrilled to combine both forces and expertise with Cyto-care.eu, a European leader in producing quality blood-based products from leukapheresis, through this strategic partnership. As the cell and gene therapy field continues to advance, the demand for leukapheresis materials is expected to increase. Clinical trials and commercial production of these therapies require a consistent and reliable supply of high-quality blood-derived products to meet patient needs.”

“Through rigorous analysis and in-depth discussions with the experts of the field, the Needle-to-Freezing time has been identified as a crucial factor for success for the development and manufacturing of ATMPs,” said Klaus Fischer, Cyto-care.eu’s Managing Director. “Through this collaboration with SCTbio, we can ensure that our leukapheresis products from patients and from donors continue to meet the high-quality standards of our customers’ requirements.”

More information online


Digital Edition

Lab Asia 31.6 Dec 2024

December 2024

Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...

View all digital editions

Events

Smart Factory Expo 2025

Jan 22 2025 Tokyo, Japan

Instrumentation Live

Jan 22 2025 Birmingham, UK

SLAS 2025

Jan 25 2025 San Diego, CA, USA

Arab Health

Jan 27 2025 Dubai, UAE

Nano Tech 2025

Jan 29 2025 Tokyo, Japan

View all events